nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—Appendicitis—Octreotide—thymus cancer	0.0375	0.0375	CcSEcCtD
Citalopram—Hypertension worsened—Octreotide—thymus cancer	0.0266	0.0266	CcSEcCtD
Citalopram—Glucose tolerance impaired—Octreotide—thymus cancer	0.0215	0.0215	CcSEcCtD
Citalopram—Breast neoplasm—Octreotide—thymus cancer	0.0192	0.0192	CcSEcCtD
Citalopram—Goitre—Octreotide—thymus cancer	0.0162	0.0162	CcSEcCtD
Citalopram—Varicose vein—Octreotide—thymus cancer	0.0156	0.0156	CcSEcCtD
Citalopram—Hypochromic anaemia—Octreotide—thymus cancer	0.015	0.015	CcSEcCtD
Citalopram—Hepatitis cholestatic—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Citalopram—VIIth nerve paralysis—Octreotide—thymus cancer	0.0141	0.0141	CcSEcCtD
Citalopram—Prostatic disorder—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Citalopram—Ear infection—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Citalopram—Loss of libido—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Citalopram—Ulcerative stomatitis—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Citalopram—Hernia—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Citalopram—Trauma—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Citalopram—Abdominal bloating—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Citalopram—Sinus bradycardia—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Citalopram—Renal pain—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Citalopram—Ear disorder—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Citalopram—Anorectal discomfort—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Citalopram—Pregnancy—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Citalopram—Cholecystitis—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Citalopram—Haemorrhoids—Octreotide—thymus cancer	0.00986	0.00986	CcSEcCtD
Citalopram—Cholelithiasis—Octreotide—thymus cancer	0.00932	0.00932	CcSEcCtD
Citalopram—Haematoma—Octreotide—thymus cancer	0.00922	0.00922	CcSEcCtD
Citalopram—Hypothyroidism—Octreotide—thymus cancer	0.00903	0.00903	CcSEcCtD
Citalopram—Galactorrhoea—Octreotide—thymus cancer	0.00894	0.00894	CcSEcCtD
Citalopram—Abdominal cramps—Octreotide—thymus cancer	0.00859	0.00859	CcSEcCtD
Citalopram—Menstrual disorder—Octreotide—thymus cancer	0.00851	0.00851	CcSEcCtD
Citalopram—Paranoia—Octreotide—thymus cancer	0.00851	0.00851	CcSEcCtD
Citalopram—Burning sensation—Octreotide—thymus cancer	0.00835	0.00835	CcSEcCtD
Citalopram—Neuralgia—Octreotide—thymus cancer	0.00835	0.00835	CcSEcCtD
Citalopram—Metrorrhagia—Octreotide—thymus cancer	0.00812	0.00812	CcSEcCtD
Citalopram—Influenza-like symptoms—Octreotide—thymus cancer	0.00812	0.00812	CcSEcCtD
Citalopram—Herpes zoster—Octreotide—thymus cancer	0.0077	0.0077	CcSEcCtD
Citalopram—Otitis media—Octreotide—thymus cancer	0.00745	0.00745	CcSEcCtD
Citalopram—Coagulopathy—Octreotide—thymus cancer	0.00745	0.00745	CcSEcCtD
Citalopram—Nephrolithiasis—Octreotide—thymus cancer	0.00721	0.00721	CcSEcCtD
Citalopram—Endocrine disorder—Octreotide—thymus cancer	0.00699	0.00699	CcSEcCtD
Citalopram—Acne—Octreotide—thymus cancer	0.00689	0.00689	CcSEcCtD
Citalopram—Breast pain—Octreotide—thymus cancer	0.00665	0.00665	CcSEcCtD
Citalopram—Contusion—Octreotide—thymus cancer	0.00665	0.00665	CcSEcCtD
Citalopram—Amenorrhoea—Octreotide—thymus cancer	0.0066	0.0066	CcSEcCtD
Citalopram—Rectal haemorrhage—Octreotide—thymus cancer	0.00642	0.00642	CcSEcCtD
Citalopram—Viral infection—Octreotide—thymus cancer	0.00642	0.00642	CcSEcCtD
Citalopram—Cellulitis—Octreotide—thymus cancer	0.00638	0.00638	CcSEcCtD
Citalopram—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00638	0.00638	CcSEcCtD
Citalopram—Arthropathy—Octreotide—thymus cancer	0.00638	0.00638	CcSEcCtD
Citalopram—Herpes simplex—Octreotide—thymus cancer	0.00629	0.00629	CcSEcCtD
Citalopram—Drug interaction—Octreotide—thymus cancer	0.00625	0.00625	CcSEcCtD
Citalopram—Muscle twitching—Octreotide—thymus cancer	0.0059	0.0059	CcSEcCtD
Citalopram—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0058	0.0058	CcSEcCtD
Citalopram—Vaginal inflammation—Octreotide—thymus cancer	0.0058	0.0058	CcSEcCtD
Citalopram—Eructation—Octreotide—thymus cancer	0.0057	0.0057	CcSEcCtD
Citalopram—Cystitis noninfective—Octreotide—thymus cancer	0.00566	0.00566	CcSEcCtD
Citalopram—Wheezing—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Citalopram—Influenza like illness—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Citalopram—Cystitis—Octreotide—thymus cancer	0.0056	0.0056	CcSEcCtD
Citalopram—Candida infection—Octreotide—thymus cancer	0.00554	0.00554	CcSEcCtD
Citalopram—Vaginal infection—Octreotide—thymus cancer	0.00547	0.00547	CcSEcCtD
Citalopram—Neuropathy—Octreotide—thymus cancer	0.00544	0.00544	CcSEcCtD
Citalopram—Cramps of lower extremities—Octreotide—thymus cancer	0.00533	0.00533	CcSEcCtD
Citalopram—Mouth ulceration—Octreotide—thymus cancer	0.00524	0.00524	CcSEcCtD
Citalopram—Bladder pain—Octreotide—thymus cancer	0.00524	0.00524	CcSEcCtD
Citalopram—Urine output increased—Octreotide—thymus cancer	0.00524	0.00524	CcSEcCtD
Citalopram—Gynaecomastia—Octreotide—thymus cancer	0.00519	0.00519	CcSEcCtD
Citalopram—Hyperkinesia—Octreotide—thymus cancer	0.00506	0.00506	CcSEcCtD
Citalopram—Phlebitis—Octreotide—thymus cancer	0.00489	0.00489	CcSEcCtD
Citalopram—Sleep disorder—Octreotide—thymus cancer	0.00486	0.00486	CcSEcCtD
Citalopram—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00484	0.00484	CcSEcCtD
Citalopram—Diabetes mellitus—Octreotide—thymus cancer	0.00484	0.00484	CcSEcCtD
Citalopram—Polyuria—Octreotide—thymus cancer	0.00479	0.00479	CcSEcCtD
Citalopram—Gastroenteritis—Octreotide—thymus cancer	0.00475	0.00475	CcSEcCtD
Citalopram—Deafness—Octreotide—thymus cancer	0.0047	0.0047	CcSEcCtD
Citalopram—Nasal congestion—Octreotide—thymus cancer	0.00462	0.00462	CcSEcCtD
Citalopram—Injury—Octreotide—thymus cancer	0.00458	0.00458	CcSEcCtD
Citalopram—Hot flush—Octreotide—thymus cancer	0.0045	0.0045	CcSEcCtD
Citalopram—Amnesia—Octreotide—thymus cancer	0.00448	0.00448	CcSEcCtD
Citalopram—Menopausal symptoms—Octreotide—thymus cancer	0.00446	0.00446	CcSEcCtD
Citalopram—Visual disturbance—Octreotide—thymus cancer	0.00444	0.00444	CcSEcCtD
Citalopram—Arthritis—Octreotide—thymus cancer	0.00433	0.00433	CcSEcCtD
Citalopram—Hypoglycaemia—Octreotide—thymus cancer	0.00431	0.00431	CcSEcCtD
Citalopram—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00421	0.00421	CcSEcCtD
Citalopram—Pain in extremity—Octreotide—thymus cancer	0.00421	0.00421	CcSEcCtD
Citalopram—Osteoarthritis—Octreotide—thymus cancer	0.00421	0.00421	CcSEcCtD
Citalopram—Psychotic disorder—Octreotide—thymus cancer	0.00411	0.00411	CcSEcCtD
Citalopram—Irritability—Octreotide—thymus cancer	0.00402	0.00402	CcSEcCtD
Citalopram—Dehydration—Octreotide—thymus cancer	0.00391	0.00391	CcSEcCtD
Citalopram—Dry skin—Octreotide—thymus cancer	0.00386	0.00386	CcSEcCtD
Citalopram—Abdominal pain upper—Octreotide—thymus cancer	0.00384	0.00384	CcSEcCtD
Citalopram—Cramp muscle—Octreotide—thymus cancer	0.00379	0.00379	CcSEcCtD
Citalopram—Nasopharyngitis—Octreotide—thymus cancer	0.00376	0.00376	CcSEcCtD
Citalopram—Gastritis—Octreotide—thymus cancer	0.00372	0.00372	CcSEcCtD
Citalopram—Muscular weakness—Octreotide—thymus cancer	0.00371	0.00371	CcSEcCtD
Citalopram—Abdominal distension—Octreotide—thymus cancer	0.00366	0.00366	CcSEcCtD
Citalopram—Influenza—Octreotide—thymus cancer	0.00364	0.00364	CcSEcCtD
Citalopram—Asthma—Octreotide—thymus cancer	0.00364	0.00364	CcSEcCtD
Citalopram—Bronchospasm—Octreotide—thymus cancer	0.00358	0.00358	CcSEcCtD
Citalopram—Pancreatitis—Octreotide—thymus cancer	0.00357	0.00357	CcSEcCtD
Citalopram—Sweating increased—Octreotide—thymus cancer	0.00354	0.00354	CcSEcCtD
Citalopram—Bronchitis—Octreotide—thymus cancer	0.0035	0.0035	CcSEcCtD
Citalopram—Abdominal discomfort—Octreotide—thymus cancer	0.00349	0.00349	CcSEcCtD
Citalopram—Dysuria—Octreotide—thymus cancer	0.0034	0.0034	CcSEcCtD
Citalopram—Upper respiratory tract infection—Octreotide—thymus cancer	0.00338	0.00338	CcSEcCtD
Citalopram—Pollakiuria—Octreotide—thymus cancer	0.00336	0.00336	CcSEcCtD
Citalopram—Weight increased—Octreotide—thymus cancer	0.00331	0.00331	CcSEcCtD
Citalopram—Weight decreased—Octreotide—thymus cancer	0.00329	0.00329	CcSEcCtD
Citalopram—Hyperglycaemia—Octreotide—thymus cancer	0.00328	0.00328	CcSEcCtD
Citalopram—Pneumonia—Octreotide—thymus cancer	0.00326	0.00326	CcSEcCtD
Citalopram—Depression—Octreotide—thymus cancer	0.00323	0.00323	CcSEcCtD
Citalopram—Neuropathy peripheral—Octreotide—thymus cancer	0.00318	0.00318	CcSEcCtD
Citalopram—Jaundice—Octreotide—thymus cancer	0.00316	0.00316	CcSEcCtD
Citalopram—Conjunctivitis—Octreotide—thymus cancer	0.00315	0.00315	CcSEcCtD
Citalopram—Urinary tract infection—Octreotide—thymus cancer	0.00315	0.00315	CcSEcCtD
Citalopram—Haematuria—Octreotide—thymus cancer	0.00309	0.00309	CcSEcCtD
Citalopram—Hepatobiliary disease—Octreotide—thymus cancer	0.00307	0.00307	CcSEcCtD
Citalopram—Epistaxis—Octreotide—thymus cancer	0.00306	0.00306	CcSEcCtD
Citalopram—Sinusitis—Octreotide—thymus cancer	0.00304	0.00304	CcSEcCtD
Citalopram—Bradycardia—Octreotide—thymus cancer	0.00296	0.00296	CcSEcCtD
Citalopram—Rhinitis—Octreotide—thymus cancer	0.00292	0.00292	CcSEcCtD
Citalopram—Hepatitis—Octreotide—thymus cancer	0.00291	0.00291	CcSEcCtD
Citalopram—Hypoaesthesia—Octreotide—thymus cancer	0.0029	0.0029	CcSEcCtD
Citalopram—Pharyngitis—Octreotide—thymus cancer	0.00289	0.00289	CcSEcCtD
Citalopram—Oedema peripheral—Octreotide—thymus cancer	0.00287	0.00287	CcSEcCtD
Citalopram—Visual impairment—Octreotide—thymus cancer	0.00281	0.00281	CcSEcCtD
Citalopram—Tinnitus—Octreotide—thymus cancer	0.00271	0.00271	CcSEcCtD
Citalopram—Cardiac disorder—Octreotide—thymus cancer	0.0027	0.0027	CcSEcCtD
Citalopram—Flushing—Octreotide—thymus cancer	0.0027	0.0027	CcSEcCtD
Citalopram—Immune system disorder—Octreotide—thymus cancer	0.00263	0.00263	CcSEcCtD
Citalopram—Arrhythmia—Octreotide—thymus cancer	0.0026	0.0026	CcSEcCtD
Citalopram—Alopecia—Octreotide—thymus cancer	0.00257	0.00257	CcSEcCtD
Citalopram—Mental disorder—Octreotide—thymus cancer	0.00255	0.00255	CcSEcCtD
Citalopram—Erythema—Octreotide—thymus cancer	0.00253	0.00253	CcSEcCtD
Citalopram—Malnutrition—Octreotide—thymus cancer	0.00253	0.00253	CcSEcCtD
Citalopram—Flatulence—Octreotide—thymus cancer	0.0025	0.0025	CcSEcCtD
Citalopram—Tension—Octreotide—thymus cancer	0.00249	0.00249	CcSEcCtD
Citalopram—Nervousness—Octreotide—thymus cancer	0.00246	0.00246	CcSEcCtD
Citalopram—Back pain—Octreotide—thymus cancer	0.00245	0.00245	CcSEcCtD
Citalopram—Muscle spasms—Octreotide—thymus cancer	0.00244	0.00244	CcSEcCtD
Citalopram—Vision blurred—Octreotide—thymus cancer	0.00239	0.00239	CcSEcCtD
Citalopram—Tremor—Octreotide—thymus cancer	0.00237	0.00237	CcSEcCtD
Citalopram—Ill-defined disorder—Octreotide—thymus cancer	0.00235	0.00235	CcSEcCtD
Citalopram—Anaemia—Octreotide—thymus cancer	0.00234	0.00234	CcSEcCtD
Citalopram—Agitation—Octreotide—thymus cancer	0.00233	0.00233	CcSEcCtD
Citalopram—Malaise—Octreotide—thymus cancer	0.00229	0.00229	CcSEcCtD
Citalopram—Vertigo—Octreotide—thymus cancer	0.00228	0.00228	CcSEcCtD
Citalopram—Syncope—Octreotide—thymus cancer	0.00227	0.00227	CcSEcCtD
Citalopram—Palpitations—Octreotide—thymus cancer	0.00224	0.00224	CcSEcCtD
Citalopram—Loss of consciousness—Octreotide—thymus cancer	0.00223	0.00223	CcSEcCtD
Citalopram—Cough—Octreotide—thymus cancer	0.00221	0.00221	CcSEcCtD
Citalopram—Convulsion—Octreotide—thymus cancer	0.0022	0.0022	CcSEcCtD
Citalopram—Hypertension—Octreotide—thymus cancer	0.00219	0.00219	CcSEcCtD
Citalopram—Chest pain—Octreotide—thymus cancer	0.00216	0.00216	CcSEcCtD
Citalopram—Myalgia—Octreotide—thymus cancer	0.00216	0.00216	CcSEcCtD
Citalopram—Arthralgia—Octreotide—thymus cancer	0.00216	0.00216	CcSEcCtD
Citalopram—Anxiety—Octreotide—thymus cancer	0.00215	0.00215	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00214	0.00214	CcSEcCtD
Citalopram—Discomfort—Octreotide—thymus cancer	0.00213	0.00213	CcSEcCtD
Citalopram—Dry mouth—Octreotide—thymus cancer	0.00211	0.00211	CcSEcCtD
Citalopram—Anaphylactic shock—Octreotide—thymus cancer	0.00207	0.00207	CcSEcCtD
Citalopram—Oedema—Octreotide—thymus cancer	0.00207	0.00207	CcSEcCtD
Citalopram—Infection—Octreotide—thymus cancer	0.00206	0.00206	CcSEcCtD
Citalopram—Shock—Octreotide—thymus cancer	0.00204	0.00204	CcSEcCtD
Citalopram—Nervous system disorder—Octreotide—thymus cancer	0.00203	0.00203	CcSEcCtD
Citalopram—Thrombocytopenia—Octreotide—thymus cancer	0.00203	0.00203	CcSEcCtD
Citalopram—Tachycardia—Octreotide—thymus cancer	0.00202	0.00202	CcSEcCtD
Citalopram—Skin disorder—Octreotide—thymus cancer	0.00201	0.00201	CcSEcCtD
Citalopram—Hyperhidrosis—Octreotide—thymus cancer	0.002	0.002	CcSEcCtD
Citalopram—Anorexia—Octreotide—thymus cancer	0.00197	0.00197	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00188	0.00188	CcSEcCtD
Citalopram—Insomnia—Octreotide—thymus cancer	0.00187	0.00187	CcSEcCtD
Citalopram—Paraesthesia—Octreotide—thymus cancer	0.00186	0.00186	CcSEcCtD
Citalopram—Dyspnoea—Octreotide—thymus cancer	0.00184	0.00184	CcSEcCtD
Citalopram—Somnolence—Octreotide—thymus cancer	0.00184	0.00184	CcSEcCtD
Citalopram—Dyspepsia—Octreotide—thymus cancer	0.00182	0.00182	CcSEcCtD
Citalopram—Decreased appetite—Octreotide—thymus cancer	0.0018	0.0018	CcSEcCtD
Citalopram—Gastrointestinal disorder—Octreotide—thymus cancer	0.00179	0.00179	CcSEcCtD
Citalopram—Fatigue—Octreotide—thymus cancer	0.00178	0.00178	CcSEcCtD
Citalopram—Constipation—Octreotide—thymus cancer	0.00177	0.00177	CcSEcCtD
Citalopram—Pain—Octreotide—thymus cancer	0.00177	0.00177	CcSEcCtD
Citalopram—Feeling abnormal—Octreotide—thymus cancer	0.0017	0.0017	CcSEcCtD
Citalopram—Gastrointestinal pain—Octreotide—thymus cancer	0.00169	0.00169	CcSEcCtD
Citalopram—Urticaria—Octreotide—thymus cancer	0.00164	0.00164	CcSEcCtD
Citalopram—Abdominal pain—Octreotide—thymus cancer	0.00164	0.00164	CcSEcCtD
Citalopram—Body temperature increased—Octreotide—thymus cancer	0.00164	0.00164	CcSEcCtD
Citalopram—Hypersensitivity—Octreotide—thymus cancer	0.00152	0.00152	CcSEcCtD
Citalopram—Asthenia—Octreotide—thymus cancer	0.00148	0.00148	CcSEcCtD
Citalopram—Pruritus—Octreotide—thymus cancer	0.00146	0.00146	CcSEcCtD
Citalopram—Diarrhoea—Octreotide—thymus cancer	0.00142	0.00142	CcSEcCtD
Citalopram—Dizziness—Octreotide—thymus cancer	0.00137	0.00137	CcSEcCtD
Citalopram—Vomiting—Octreotide—thymus cancer	0.00132	0.00132	CcSEcCtD
Citalopram—Rash—Octreotide—thymus cancer	0.0013	0.0013	CcSEcCtD
Citalopram—Dermatitis—Octreotide—thymus cancer	0.0013	0.0013	CcSEcCtD
Citalopram—Headache—Octreotide—thymus cancer	0.0013	0.0013	CcSEcCtD
Citalopram—Nausea—Octreotide—thymus cancer	0.00123	0.00123	CcSEcCtD
